HIGHLIGHTS
- who: β-catenin/TCF et al. from the Department of Chinese Internal Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China have published the research work: Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β -Catenin/TCF4 Interaction, in the Journal: (JOURNAL)
- what: This study was approved by the Institutional Review Board of the Teaching Hospital of Chengdu University of TCM (Chengdu, China) (approval no. 2018KL-023) and written informed consent was obtained from all participants for being included in the study. The analysis demonstrated that rate of nuclear September 2021 | Volume 12 | Article . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.